查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1545540

全球生命科学分析市场

Life Science Analytics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球生命科学分析市场预计将达到 746 亿美元

全球生命科学分析市场预计到 2023 年将达到 310 亿美元，预计到 2030 年将达到 746 亿美元，2023-2030 年分析期间复合年增长率为 13.4%。生命科学分析服务是本报告分析的细分市场之一，预计复合年增长率为 14.1%，到分析期结束时将达到 447 亿美元。在分析期间，生命科学分析软体产业的复合年增长率预计为 12.3%。

美国市场预计将成长83亿美元，中国复合年增长率为12.2%

到 2023 年，美国生命科学分析市场预计将达到 83 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达112亿美元，2023-2030年分析期间复合年增长率为12.2%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 12.2% 和 11.2%。在欧洲，德国预计复合年增长率为 9.3%。

全球生命科学分析市场—主要趋势与驱动因素总结

为什么生命科学分析对于医疗保健和研究变得至关重要？

随着公司越来越依赖资料主导的见解来改善患者治疗结果、加速药物开发、提高业务效率等，生命科学分析对于医疗保健和研究变得至关重要。透过利用人工智慧 (AI) 和机器学习等先进的分析工具，生命科学公司可以分析来自临床试验、电子健康记录和基因组学的资料，以揭示可为决策提供资讯的模式和趋势。这些资料主导的方法有助于个人化护理、优化临床试验并简化研发流程，使生命科学分析成为现代医疗保健生态系统的重要组成部分。

技术进步如何形塑生命科学分析市场？

技术进步显着增强了生命科学分析的能力和应用。将人工智慧和机器学习演算法整合到分析平台中可以实现更高级的资料分析，使研究人员和医疗保健提供者能够识别以前难以或不可能检测到的见解。云端运算也透过为储存和处理大型资料集提供可扩展且安全的环境而发挥重要作用。此外，资料视觉化工具的进步使非技术用户更容易解释复杂的资料，从而在整个生命科学产业做出更明智的决策。这些技术创新正在推动先进分析解决方案的采用，并推动生命科学分析市场的成长。

生命科学分析市场有哪些新趋势？

塑造生命科学分析市场的新兴市场趋势包括对个人化医疗的更多关注、在药物开发中更多地使用现实世界证据以及转向基于价值的护理。个人化医疗根据遗传倾向和其他因素为个别患者量身定制治疗方法，并在很大程度上依赖先进的分析来确定最有效的治疗方法。使用真实世界的证据来分析电子健康记录和患者登记等资料，作为支持药物开发和监管决策的一种方式也引起了人们的关注。此外，向强调患者治疗效果和成本效益的基于价值的护理的转变正在推动对能够追踪和衡量医疗保健绩效的分析解决方案的需求。这些趋势正在促进生命科学分析市场的动态成长。

推动生命科学分析市场成长的因素有哪些？

生命科学分析市场的成长受到多种因素的推动，包括医疗保健和研究领域越来越多地采用先进的分析工具、对个人化医疗的日益重视以及生命科学产业对资料驱动决策的需求不断增长。被拖走。电子健康记录、临床试验和基因组学生成的医疗保健资料的扩展是一个关键驱动因素，创造了对能够处理和解释这些资料的强大分析解决方案的需求。此外，对基于价值观的医学的推动以及在药物开发中使用真实世界证据正在推动分析解决方案的采用。随着生命科学产业的不断发展，对高阶分析的需求将会增加，市场预计将继续成长。

受访企业范例（44家知名企业）

  • Accenture PLC
  • Cognizant Technology Solutions Corporation
  • IBM Corporation
  • IQVIA
  • MaxisIT Inc.
  • Oracle Corporation
  • SAS Institute, Inc.
  • SCIO Health Analytics, an EXL company
  • TAKE Solutions
  • Wipro Ltd.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP13011

Global Life Science Analytics Market to Reach US$74.6 Billion by 2030

The global market for Life Science Analytics estimated at US$31.0 Billion in the year 2023, is expected to reach US$74.6 Billion by 2030, growing at a CAGR of 13.4% over the analysis period 2023-2030. Life Science Analytics Services, one of the segments analyzed in the report, is expected to record a 14.1% CAGR and reach US$44.7 Billion by the end of the analysis period. Growth in the Life Science Analytics Software segment is estimated at 12.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.3 Billion While China is Forecast to Grow at 12.2% CAGR

The Life Science Analytics market in the U.S. is estimated at US$8.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$11.2 Billion by the year 2030 trailing a CAGR of 12.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.2% and 11.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.3% CAGR.

Global Life Science Analytics Market - Key Trends & Drivers Summarized

Why Is Life Science Analytics Becoming Integral to Healthcare and Research?

Life science analytics is becoming integral to healthcare and research as organizations increasingly rely on data-driven insights to improve patient outcomes, accelerate drug development, and enhance operational efficiency. By leveraging advanced analytics tools, such as artificial intelligence (AI) and machine learning, life science companies can analyze vast amounts of data from clinical trials, electronic health records, and genomics to uncover patterns and trends that inform decision-making. This data-driven approach is helping to personalize medicine, optimize clinical trials, and streamline research and development processes, making life science analytics a critical component in the modern healthcare ecosystem.

How Are Technological Advancements Shaping the Life Science Analytics Market?

Technological advancements are significantly enhancing the capabilities and applications of life science analytics. The integration of AI and machine learning algorithms into analytics platforms is enabling more sophisticated data analysis, allowing researchers and healthcare providers to identify insights that were previously difficult or impossible to detect. Cloud computing is also playing a key role by providing scalable and secure environments for storing and processing large datasets. Additionally, advancements in data visualization tools are making it easier for non-technical users to interpret complex data, leading to more informed decision-making across the life sciences industry. These technological innovations are driving the adoption of advanced analytics solutions, fueling growth in the life science analytics market.

What Are the Emerging Trends in the Life Science Analytics Market?

Several emerging trends are shaping the life science analytics market, including the increasing focus on personalized medicine, the growing use of real-world evidence in drug development, and the shift towards value-based care. Personalized medicine, which tailors treatments to individual patients based on their genetic makeup and other factors, is heavily reliant on advanced analytics to identify the most effective therapies. The use of real-world evidence, which involves analyzing data from sources such as electronic health records and patient registries, is also gaining traction as a way to support drug development and regulatory decision-making. Additionally, the shift towards value-based care, which emphasizes patient outcomes and cost-effectiveness, is driving the need for analytics solutions that can track and measure healthcare performance. These trends are contributing to the dynamic growth of the life science analytics market.

What Factors Are Driving the Growth of the Life Science Analytics Market?

The growth in the life science analytics market is driven by several factors, including the increasing adoption of advanced analytics tools in healthcare and research, the growing emphasis on personalized medicine, and the rising need for data-driven decision-making in the life sciences industry. The expansion of healthcare data, generated by electronic health records, clinical trials, and genomics, is a significant driver, as it creates a demand for powerful analytics solutions that can process and interpret this data. Additionally, the push towards value-based care and the use of real-world evidence in drug development are driving the adoption of analytics solutions. As the life sciences industry continues to evolve, the demand for advanced analytics is expected to grow, driving sustained growth in the market.

Select Competitors (Total 44 Featured) -

  • Accenture PLC
  • Cognizant Technology Solutions Corporation
  • IBM Corporation
  • IQVIA
  • MaxisIT Inc.
  • Oracle Corporation
  • SAS Institute, Inc.
  • SCIO Health Analytics, an EXL company
  • TAKE Solutions
  • Wipro Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • An Introduction to Life Science Analytics
    • Life Science Analytics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Relevance of Big Data Analytics to Improve Productivity in Life Science Industry
    • AI, ML & Big Data Transform Clinical Trials Market
    • Increasing Prevalence of Chronic Diseases Boosts Market Prospects
    • Need to Curb Surging Healthcare Spending & Improve Patient Outcomes Enhance Importance of Analytics
    • Growing Use of Analytics in Personalized and Precision Medicine: A Major Growth Opportunity
    • Global Precision Medicine Market Size (US$ Billion) for the Years 2019, 2022 and 2025
    • Growing Demand for Data-Driven Insights Spurs Growth in Life Science Analytics
    • Advancements in Big Data and AI Propel Adoption of Analytics in Life Sciences
    • Shift Towards Personalized Medicine Expands Addressable Market for Life Science Analytics
    • Rising Focus on Clinical Trials and Drug Development Drives Adoption of Advanced Analytics
    • Growing Application of Predictive Analytics in Patient Care Strengthens Market Demand
    • Technological Innovations in Cloud Computing Enhance Scalability and Accessibility of Analytics
    • Expanding Use of Real-World Data in Pharmaceutical Research Generates New Opportunities
    • Rising Importance of Analytics in Biomarker Discovery and Validation Strengthens Demand
    • Technological Advancements in Machine Learning and AI Algorithms Expand Market Potential
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Life Science Analytics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Life Science Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Life Science Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Descriptive Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Descriptive Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Predictive Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Predictive Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Prescriptive Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Prescriptive Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 19: World 7-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Medical Device Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World 7-Year Perspective for Medical Device Manufacturers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Research Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World 7-Year Perspective for Research Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Third-Party Administrators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 25: World 7-Year Perspective for Third-Party Administrators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 29: USA 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 31: USA 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
  • CANADA
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 35: Canada 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Canada 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Canada 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
  • JAPAN
    • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 43: Japan 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Japan 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Japan 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
  • CHINA
    • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
    • TABLE 52: China Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 53: China 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
    • TABLE 54: China Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 55: China 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
  • EUROPE
    • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 58: Europe Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Europe 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Life Science Analytics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 61: Europe 7-Year Perspective for Life Science Analytics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Europe 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Europe 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
  • FRANCE
    • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
    • TABLE 70: France Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 71: France 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
    • TABLE 72: France Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 73: France 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
  • GERMANY
    • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 76: Germany Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 77: Germany 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
    • TABLE 78: Germany Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 79: Germany 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Germany 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 83: Germany 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
  • ITALY
    • TABLE 84: Italy Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 85: Italy 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Italy 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 89: Italy 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 91: Italy 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
  • UNITED KINGDOM
    • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 92: UK Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: UK 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
    • TABLE 94: UK Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 95: UK 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
    • TABLE 96: UK Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 97: UK 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: UK 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 100: Rest of Europe Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 101: Rest of Europe 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
    • TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 103: Rest of Europe 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 108: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 109: Asia-Pacific 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 116: Rest of World Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Rest of World 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
    • TABLE 118: Rest of World Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 119: Rest of World 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 121: Rest of World 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of World 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030

IV. COMPETITION